SAB Biotherapeutics enters new exec employment agreements with President and COO

SAB Biotherapeutics, Inc.

President Eddie J. Sullivan gets annual base salary of $485,000; eligible for bonus up to 50% of salary.
COO Christoph Bausch gets annual base salary of $425,000; eligible for bonus up to 40% of salary.
Agreements effective Jan 1, 2024, replacing prior employment pacts; standard non-compete and non-solicit included.
No changes to board or officer composition; both executives remain in same roles.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.